SeraCare™ ACCURUN™ 644 Cystic Fibrosis 40plus4 Control

A synthetic, multiplex control formulated for research use in laboratory testing, molecular screening, and mutation testing

• Identifies mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
• Covers all 47 mutations in the Prima xTAG™ CFTR IVD Assay
• Eliminate errors arising from use of rotating gDNA control schemes with incomplete mutation profiles
• Controls contain a mixture of oligonucleotides that produce a call for every mutation tested
• All mutations contained in a single vial
• High purity, large lots, stable materials–no additional processing required

Not for use in diagnostic procedures

Certifications/Compliance

CE, RUO

Type

ACCURUN 644 Cystic Fibrosis 40+4 Control

Intended Use

Detects significant errors with the use of rotating gDNA control schemes, research use only

Quantity

100 μL